They found that IL-6 and CRP (but not TNF-α or IL-8) significantly increased from T1 to T2 before returning to baseline levels by T3, and these early increases were not associated with post-treatment depression severity (Kruse et al., 2018). The gene discussed is IL6; the disease is depressive symptom measurement.